tirzepatide and hair growth I Cut Off My - My Mounjaro Hair Loss Journey Tirzepatide Hair Loss: Causes, Prevention,

10.1016/j.semcdb.2012.03.017 117 ZhangG.YaoQ.LongC.YiP.SongJ.WuL.et al (2025)

When Gas and Bloating Warrant Dose Adjustment or Provider Contact Most tirzepatide-related gas and bloating are mild to moderate and self-limiting, but severe or persistent symptoms may signal a need for dose adjustment

Evidence from the SURPASS phase III clinical trial program has consistently demonstrated the superior metabolic efficacy of tirzepatide compared with currently available GLP-1 receptor agonists, such as semaglutide

Glucagon-like peptide-1 (GLP-1) receptor agonist therapy helps prevent kidney events and reduce mortality in patients with type 2 diabetes and chronic kidney disease (CKD) irrespective of whether or not they have established atherosclerotic cardiovascular disease (ASCVD) or high total CVD risk, a secondary analysis of the FLOW trial suggests